Literature DB >> 12011271

Diagnostic lessons from the spectrum study.

R B Lipton1, R K Cady, W F Stewart, K Wilks, C Hall.   

Abstract

Article abstract Migraine is a heterogeneous condition that causes symptoms that vary both among individuals and within individuals from attack to attack. We examined and reviewed several important lessons on the diagnosis of migraine learned from the distribution of headache types and patterns of treatment response in the Spectrum Study, including recruitment and diagnostic issues. The accuracy of an initial diagnosis, assigned by a clinician in the context of a clinical trial, was compared with the results of a final diagnosis, assigned by a neurologist, reviewing the initial evaluation as well as headache diaries for up to 10 attacks. Several lessons can be learned from the Spectrum Study. Recruitment difficulties teach us that disabling tension-type headache is difficult to find, suggesting that it is rare. Examination of the final diagnosis given after diary evaluations suggests that a diagnosis of migraine can usually be confirmed for patients with disabling headache. After reclassification of the final sample of 432 subjects, 24/75 (32%) patients initially clinically classified as having disabling episodic tension-type headache proved to have migraine or migrainous headache after a diary review. Among study participants, 90% of subjects with disabling headache (HIMQ score >250) had a migraine-related disorder. Treatment response suggests that, in migraineurs, tension-type headaches may have a pathophysiology similar to that of migraine. The diary data show that mild headaches in patients with disabling migraine often evolve into full-blown migraine. The Spectrum Study supports the view that, for patients with disabling episodic headache, migraine is often the correct diagnosis. In clinical practice, the suspicion of migraine should be high for patients experiencing episodic disabling headache. Assessment of headache-related disability may assist practitioners in making a diagnosis of migraine.

Entities:  

Mesh:

Year:  2002        PMID: 12011271     DOI: 10.1212/wnl.58.9_suppl_6.s27

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  22 in total

Review 1.  Pure tension-type headache versus tension-type headache in the migraineur.

Authors:  Andrew Blumenfeld; Jack Schim; Jessica Brower
Journal:  Curr Pain Headache Rep       Date:  2010-12

2.  Easing the pain: challenges and opportunities in headache management.

Authors:  David P B Watson
Journal:  Br J Gen Pract       Date:  2008-02       Impact factor: 5.386

3.  The future of migraine: beyond just another pill.

Authors:  Roger K Cady
Journal:  Mayo Clin Proc       Date:  2009-05       Impact factor: 7.616

Review 4.  Diagnostic issues in tension-type headache.

Authors:  Sara Sacco
Journal:  Curr Pain Headache Rep       Date:  2008-12

Review 5.  Brain Excitability in Tension-Type Headache: a Separate Entity from Migraine?

Authors:  Wei-Ta Chen; Fu-Jung Hsiao; Shuu-Jiun Wang
Journal:  Curr Pain Headache Rep       Date:  2021-01-07

6.  Drug and Nondrug Treatment in Tension-type Headache.

Authors:  Lars Bendtsen
Journal:  Ther Adv Neurol Disord       Date:  2009-05       Impact factor: 6.570

Review 7.  Migraine headache: options for acute treatment.

Authors:  Frederick R Taylor
Journal:  Curr Neurol Neurosci Rep       Date:  2005-03       Impact factor: 5.081

Review 8.  Sinus problems as a cause of headache refractoriness and migraine chronification.

Authors:  Roger K Cady; Curtis P Schreiber
Journal:  Curr Pain Headache Rep       Date:  2009-08

9.  A randomized trial of intravenous ketorolac versus intravenous metoclopramide plus diphenhydramine for tension-type and all nonmigraine, noncluster recurrent headaches.

Authors:  Benjamin W Friedman; Victoria Adewunmi; Caron Campbell; Clemencia Solorzano; David Esses; Polly E Bijur; E John Gallagher
Journal:  Ann Emerg Med       Date:  2013-04-06       Impact factor: 5.721

10.  Primary Headache Disorders: Focus on Migraine.

Authors:  Anish Bahra
Journal:  Rev Pain       Date:  2011-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.